SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-330268
Filing Date
2017-11-02
Accepted
2017-11-02 07:31:56
Documents
3
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d460787d8k.htm 8-K 15796
2 EX-99.1 d460787dex991.htm EX-99.1 72954
3 GRAPHIC g460787g06z01.jpg GRAPHIC 3529
  Complete submission text file 0001193125-17-330268.txt   95032
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 171170739
SIC: 2834 Pharmaceutical Preparations